Free Trial

Castle Biosciences (CSTL) Earnings Date, Estimates & Call Transcripts

Castle Biosciences logo
$25.75 -0.40 (-1.53%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$25.74 0.00 (-0.02%)
As of 02/21/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Get Castle Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Castle Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CSTL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CSTL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Castle Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251-$0.07-$0.07-$0.07 
Q2 20251-$0.42-$0.42-$0.42 
Q3 20251-$0.29-$0.29-$0.29 
Q4 20251-$0.36-$0.36-$0.36 
FY 20254($1.14)($1.14) ($1.14)

Castle Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2025
(Estimated)
-------
11/4/2024Q3 2024-$0.06$0.08+$0.14$0.08$78.55M$85.78M
8/5/2024Q2 2024-$0.16$0.31+$0.47$0.31$69.95M$87.00M
5/2/2024Q1 2024-$0.37-$0.09+$0.28-$0.09$68.34M$72.97M
2/28/2024Q4 2023-$0.84-$0.10+$0.74-$0.10$51.32M$66.12M
11/2/2023Q3 2023-$0.92-$0.26+$0.66-$0.26$44.94M$61.49M
8/2/2023Q2 2023-$1.01-$0.70+$0.31-$0.70$43.51M$50.14M
5/3/2023Q1 2023-$0.80-$1.10 -$0.30-$1.10$37.63M$42.04M
2/28/2023Q4 2022-$0.91-$0.78+$0.13-$0.78$36.53M$38.34M

Castle Biosciences Earnings - Frequently Asked Questions

Castle Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based off last year's report dates. Learn more on CSTL's earnings history.

Castle Biosciences updated its FY 2024 earnings guidance on Monday, January, 13th. The company issued revenue guidance of $330.0 million-, compared to the consensus revenue estimate of $326.0 million.

Castle Biosciences (NASDAQ:CSTL) has a recorded annual revenue of $219.79 million.

Castle Biosciences (NASDAQ:CSTL) has a recorded net income of -$57.47 million. CSTL has generated $0.20 earnings per share over the last four quarters.

Castle Biosciences (NASDAQ:CSTL) has a trailing price-to-earnings ratio of 128.76 and a forward price-to-earnings ratio of 58.52.

Castle Biosciences's earnings are expected to decrease from $0.44 per share to ($1.51) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CSTL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners